“Whoa! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Is Rehospitalization After Heart Failure Admission a Marker of Poor Quality?

In the U.S., there are over 1 million hospitalizations for heart failure annually ( 1–3 ). This number appears to be increasing each year and equally affecting men and women. Rehospitalization following heart failure admissions remains high, with recent reports from the Centers for Medicaid and Medicare Services suggesting that hospitalization rates may approach 25% at 30 days, and this may exceed 50% in some health systems ( 4–8 ). In addition, recurrent hospitalization following heart failure admission and myocardial infarction admission have become indicators of quality outcomes ( 9 ). Report cards for hospitals in the U.S. that care for Medicare patients have been publicly reported and highlighted in the media and public Websites. Some of the top 10 heart centers in the U.S. had low 30-day mortality rates, but higher than average rehospitalization rates ( 7 ). This raises the question as to whether rehospitalization following a heart failure admission is an appropriate indicator of quality for the health system.</P>In this issue of the Journal , Heidenreich et al. ( 10 ) provide valuable new insights into why rehospitalization is not a marker of poor quality following heart failure admission at 30 days. This report from http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the American College of Cardiology Elsevier

Loading next page...

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.